tiprankstipranks

Tamara Maes Insider Profile

4 Followers
Tamara Maes, Chief Scientific Officer at Oryzon Genomics SA, holds 2.49M shares in Oryzon Genomics SA (Ticker: DE:ORN). Most recently, Tamara Maes Sold €1,000,000 shares of Oryzon Genomics SA on Mar 01, 2021 for an estimated value of 3.57M.
tipranks
Tamara  Maes

Tamara Maes
Oryzon Genomics SA (ORN)
Chief Scientific Officer

Ranked #36,423 out of 97,825 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+26.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

€4M
100.00%
A breakdown of Tamara Maes's holdings

Insider Roles

Oryzon Genomics SA
(ORN)
Chief Scientific Officer
Roles that Tamara Maes holds in companies

Most Profitable Insider Trade

Stock:
Oryzon Genomics SA
(ORN)
Rating:Informative Sell
Date:Mar 01, 2021 - Mar 01, 2022
Return:+28.40%
The most profitable trade made by Tamara Maes

Tamara Maes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oryzon Genomics SA
Mar 01, 2021
Chief Scientific Officer
Informative Sell
3.57M
€4.20M
Success Rate for
ORN
2 out of 2 profitable transactions on
ORN
100%
Average Return for
ORN
Average return per transaction on
ORN
+26.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 31, 2020
Informative Sell
€930.00K
-
€3.72
+24.20%
Mar 01, 2021
Informative Sell
€3.57M
-
€3.57
+28.40%
List of latest transactions for each holding click on a transaction to see Tamara Maes's performance on stock

Tamara Maes insider profile FAQ

What is the percentage of profitable transactions made by Tamara Maes?
The percentage of profitable transactions made by Tamara Maes is 100%.
    What is the average return per transaction made by Tamara Maes?
    The average return per transaction made by Tamara Maes is 26.30%.
      What stocks does Tamara Maes hold?
      Tamara Maes holds: DE:ORN stocks.
        What was Tamara Maes’s latest transaction?
        Tamara Maes latest transaction was an Informative Sell of €3.57M.
          What was Tamara Maes's most profitable transaction?
          Tamara Maes’s most profitable transaction was an Informative Sell of DE:ORN stock on March 1, 2021. The return on the trade was 28.40%.
            What is Tamara Maes's role in Oryzon Genomics SA?
            Tamara Maes's role in Oryzon Genomics SA is Chief Scientific Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.